The ASBOE Hansen sign is a neurological indicator used in early assessments of upper motor neuron dysfunction. It helps clinicians identify subtle neuromuscular changes that may reflect corticospinal tract involvement before more obvious signs appear.
Observing this sign supports timely clinical decisions and guides further diagnostic testing. The following sections clarify how it is elicited, interpreted, and reported in neurological practice.
| Feature | Description | Clinical Relevance | Documentation Example |
|---|---|---|---|
| Definition | Involuntary muscle contraction triggered by tendon tap in a patient with latent dystonia | Potential marker of basal ganglia or corticospinal pathway dysfunction | Present in right upper limb, absent in lower limbs |
| Elicitation | Tap the tendon of the brachioradialis or patellar tendon with a reflex hammer | May reveal subtle myoclonic or dystonic responses not visible at rest | Light, brisk tap with limb relaxed and supported |
| Interpretation | Positive when a sudden, brief abnormal movement follows the tap | Suggests irritability of the motor system, warranting further workup | Recorded as + or – depending on consistency and amplitude |
| Differential Context | Can resemble signs of spasticity, rigidity, or dystonia | Integration with imaging and lab data improves diagnostic accuracy | MRI, EMG, and genetic testing when indicated |
Clinical Assessment of ASBOE Hansen Sign
A systematic bedside evaluation enhances the reliability of detecting the ASBOE Hansen sign. Standardized positioning and consistent stimulus intensity reduce observer variability.
Key Steps
Begin with the patient relaxed and the target limb supported. Deliver a standardized tap using a reflex hammer, and observe for both visible and palpable responses. Note side, location, timing, and associated movements to support accurate reporting.
Neurophysiological Mechanisms
The sign reflects abnormal excitability along corticospinal or extrapyramidal pathways. Disruption of inhibitory control may permit transient co-activation of agonist and antagonist muscle groups.
Pathophysiological Links
Myelination changes, cortical disinhibition, or altered basal ganglia output can contribute to the elicited response. Correlation with electrophysiological studies helps delineate the lesion level.
Differential Diagnosis and Mimics
Several movement features may resemble the ASBOE Hansen sign but arise from distinct mechanisms. Careful history and multimodal examination clarify the source.
- Spasticity velocity dependence and clasp-knife phenomenon
- Myoclonus triggered by proprioceptive stimuli
- Dystonic reactions to specific maneuvers
- Normal tendon reflexes with augmentation in anxiety or hyperthyroidism
Prognostic and Treatment Implications
Identifying the ASBOE Hansen sign early informs monitoring intensity and choice of interventions. It does not replace comprehensive evaluation but adds a measurable parameter to the neurological profile.
Therapeutic strategies may include pharmacologic modulation, physical therapy, or device-based approaches tailored to underlying etiology. Serial exams track evolution and response to intervention.
Integration Into Routine Neurological Practice
Consistent documentation and multidisciplinary discussion support appropriate use of the ASBOE Hansen sign in both acute and chronic neurological conditions.
- Incorporate the sign into standard neurological examinations when upper motor neuron features are suspected
- Correlate with imaging, EMG, and laboratory data for a comprehensive interpretation
- Track changes over time to guide therapy and monitor disease progression
- Communicate findings clearly in reports to inform referring providers and rehabilitation teams
FAQ
Reader questions
What patient population most commonly shows a positive ASBOE Hansen sign?
It is most often observed in individuals with suspected upper motor neuron lesions, movement disorders, or conditions affecting basal ganglia-thalamocortical circuits, pending confirmation with imaging and electrophysiology.
Can medications influence the presence or intensity of this sign?
Yes, dopaminergic agents, antispastics, and certain neuromodulators may alter response amplitude or threshold, so current medications should be documented during assessment.
How does this sign differ from a clonus or myoclonus triggered by tendon tap?
Clonus features rhythmic oscillations, while myoclonus shows shock-like jerks; the ASBOE Hansen sign typically denotes a single, brief dystonic or abnormal movement component distinct in morphology and presumed pathophysiology.